SCHEMBL7884266

SCHEMBL7884266

C[C@H]1CC[C@H]2[C@@H]3CC(=O)C4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP19A1 P11511 12/20 0.68
CYP3A4 P08684 5/20 0.51
LMNA P02545 5/20 0.50
SHBG P04278 4/20 0.50
SERPINA6 P08185 4/20 0.50
TSHR P16473 4/20 0.50
HSD17B10 Q99714 3/20 0.50
NR3C1 P04150 3/20 0.50
PGR P06401 3/20 0.50
AR P10275 3/20 0.50
GPBAR1 Q8TDU6 3/20 0.50
SIGMAR1 Q99720 3/20 0.50
SNCA P37840 2/20 0.50
CACNA1C Q13936 2/20 0.50
CYP51A1 Q16850 2/20 0.50
MAPT P10636 2/20 0.50
MAPK1 P28482 2/20 0.50
OR51E2 Q9H255 1/20 0.50
CYP2C9 P11712 2/20 0.47
HIF1A Q16665 2/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7520546 1.00 CYP19A1 (0.68) CYP19A1CYP3A4LMNASHBGSERPINA6
SCHEMBL2600423 0.86 CYP3A4 (0.69) CYP19A1CYP3A4LMNASHBGSERPINA6
SCHEMBL11754343 0.86 CYP3A4 (0.69) CYP19A1CYP3A4LMNASHBGSERPINA6
SCHEMBL11754338 0.86 CYP3A4 (0.69) CYP19A1CYP3A4LMNASHBGSERPINA6
SCHEMBL2600417 0.84 CYP19A1 (0.64) CYP19A1CYP3A4LMNASHBGSERPINA6
SCHEMBL11425175 0.84 CYP19A1 (0.64) CYP19A1CYP3A4LMNASHBGSERPINA6
SCHEMBL2905967 0.83 CYP19A1 (0.62) CYP19A1CYP3A4LMNASHBGSERPINA6
SCHEMBL37618 0.83 CYP3A4 (0.70) CYP19A1CYP3A4LMNASHBGSERPINA6
SCHEMBL7884191 0.82 CYP19A1 (0.61) CYP19A1CYP3A4LMNASHBGSERPINA6
SCHEMBL9056946 0.82 CYP19A1 (0.61) CYP19A1CYP3A4LMNASHBGSERPINA6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6331534-B1 ADMINISTERING EFFECTIVE AMOUNT OF STEROID WITHIN NASAL PASSAGE OF INDIVIDUAL SUCH THAT IT BINDS SPECIFICALLY TO RECEPTORS ON SURFACE OF NASAL NEUROEPITHELIAL CELLS IN VOMERONASAL ORGAN PHERIN PHARMACEUTICALS, INC. 2001-12-18 US disclosed
US-6066627-A ALTERING BLOOD CONCNETRATION OF LUTEINIZING HORMONE PHERIN CORPORATION (US) 2000-05-23 US disclosed
US-6057439-A EPOXYSTEROIDS PHERIN CORPORATION (US) 2000-05-02 US disclosed
US-5969168-A STIMULATE AUTONOMIC ACTIVITY PHERIN CORPORATION (US) 1999-10-19 US disclosed